COST-EFFECTIVENESS OF METFORMIN-GLIMEPIRIDE COMBINATION COMPARED TO SINGLE METFORMIN USE IN DECREASING 2 H POST PRANDIAL BLOOD GLUCOSE
Open Access
- 15 February 2024
- journal article
- research article
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
- p. 53-57
Abstract
Objective: Complications related to diabetes could reduce the quality of life. In Indonesia, the costs incurred for diabetes mellitus annually will increase as complications of the disease increase. This study explored the cost-effectiveness therapy of metformin-glimepiride combination on post-prandial blood glucose. Methods: Glimepiride is added to the first category for diabetes mellitus receiving metformin to improve blood sugar levels and reduce costs. An observational study was conducted retrospectively to analyze post-prandial blood sugar levels with the total direct medical costs at Universitas Andalas Hospital. The study involved 114 medical records of patients referred during 2021. The combination of Metformin HCL and Glimepiride was compared to Metformin alone in measuring cost and effect parameters. The categorical dependent-independent groups were statistically analyzed using Chi-square, while the cost and effect parameters were calculated to get the Incremental Cost-Effectiveness Ratio (ICER) value. Results: There were no significant differences between groups on sociodemographic characteristics (p<0.05). An incremental cost value of IDR 43,291 was obtained for reducing post-prandial blood sugar by 21.92 mg/dl. Conclusion: Increasing cost and effect parameters require further analysis to determine the trade-off point.Keywords
This publication has 17 references indexed in Scilit:
- The usability testing of the integrated electronic healthcare services for diabetes mellitus patients during the pandemic in IndonesiaDigital Health, 2023
- Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic EvaluationsValue in Health, 2022
- Probiotic effect of fermented milk from Pediococcus acidilactici BK01 in fecal wistar rat microfloraIOP Conference Series: Earth and Environmental Science, 2021
- Future challenge on probiotics uses from fermented milk on the endocrine disorder in humanIOP Conference Series: Earth and Environmental Science, 2021
- Design and characterization of a SYBR Green I-based melting curve method for investigation of HER2I655V polymorphism in breast cancerJournal of Genetic Engineering and Biotechnology, 2021
- A comparison study on efficacy, insulin sensitivity and safety of Glimepiride/Metformin fixed dose combination versus glimepiride single therapy on type 2 diabetes mellitus patients with basal insulin therapyDiabetes Research and Clinical Practice, 2019
- Cost-effectiveness of controlling gestational diabetes mellitus: a systematic reviewThe European Journal of Health Economics, 2018
- Cost-effectiveness analysis of metformin+dipeptidyl peptidase-4 inhibitors compared to metformin+sulfonylureas for treatment of type 2 diabetesBMC Health Services Research, 2018
- The Economic Burden of Self-Reported and Undiagnosed Cardiovascular Diseases and Diabetes on Indonesian HouseholdsPLOS ONE, 2014
- Oral Hypoglycemic Agents in pregnancy: An UpdateThe Journal of Obstetrics and Gynecology of India, 2013